Clinical benefit with docetaxel plus fluorouracil and cisplatin compared with cisplatin and fluorouracil in a phase III trial of advanced gastric or gastroesophageal cancer adenocarcinoma: the V-325 Study Group (Q80704657)
Jump to navigation
Jump to search
scientific article published on 01 August 2007
Language | Label | Description | Also known as |
---|---|---|---|
English | Clinical benefit with docetaxel plus fluorouracil and cisplatin compared with cisplatin and fluorouracil in a phase III trial of advanced gastric or gastroesophageal cancer adenocarcinoma: the V-325 Study Group |
scientific article published on 01 August 2007 |
Statements
Clinical benefit with docetaxel plus fluorouracil and cisplatin compared with cisplatin and fluorouracil in a phase III trial of advanced gastric or gastroesophageal cancer adenocarcinoma: the V-325 Study Group (English)
Jaffer A Ajani
Sergei Tjulandin
Alejandro Majlis
Corrado Boni
Adriano Rodrigues
Miguel Fodor
Yee Chao
Edouard Voznyi
Manuel Constenla
Cindy Marabotti
Eric Van Cutsem